Results 101 to 110 of about 65,470 (161)

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

open access: yesFrontiers in Immunology
BackgroundSerum biomarkers as neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) enabled early identification of multiple sclerosis (MS) patients at risk of relapse-associated worsening (RAW) or progression independent of ...
Alexander Rodero-Romero   +26 more
doaj   +1 more source

Prevalencia de Esclerosis Múltiple en Lima - Perú

open access: yes, 2009
La Esclerosis Múltiple (EM) es la principal enfermedad desmielinizante a nivel mundial. La epidemiología señala una mayor prevalencia de esta entidad en áreas alejadas de la línea ecuatorial.
Alan Juárez Belaúnde   +6 more
core  

Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study

open access: yesFrontiers in Immunology
IntroductionThere are no reports in LATAM related to longitudinal humoral and cellular response to adenovirus based COVID-19 vaccines in people with Multiple Sclerosis (pwMS) under different disease modifying therapies (DMTs) and neutralization of the ...
Berenice Anabel Silva   +38 more
doaj   +1 more source

[Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis]. [PDF]

open access: yesRev Neurol, 2022
García-Estévez DA   +4 more
europepmc   +1 more source

Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2

open access: yesNeurología, 2020
G. Álvarez Bravo, L. Ramió i Torrentà
doaj   +1 more source

[Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report]. [PDF]

open access: yesRev Neurol, 2022
Lafuente-Gómez G   +11 more
europepmc   +1 more source

SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis. [PDF]

open access: yesNeurologia (Engl Ed), 2021
Piñar Morales R   +2 more
europepmc   +1 more source

La esclerosis múltiple, 130 años después

open access: yes, 2009
La esclerosis múltiple, 130 años ...
Gonzalo Ocejo Vinyals, Javier   +1 more
core  

Erratum to ‘‘Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm’’ [Neurologia. 2020;35(6):357–362]

open access: yesNeurología (English Edition), 2020
G. Valero-López   +10 more
doaj   +1 more source

Controversies in neuroimmunology: Multiple sclerosis and other demyelinating disorders [PDF]

open access: yesBiomedica
Villegas AC   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy